UnitedHealth Group Incorporated $UNH Position Reduced by Schnieders Capital Management LLC

Schnieders Capital Management LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.5% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 11,090 shares of the healthcare conglomerate’s stock after selling 1,024 shares during the period. Schnieders Capital Management LLC’s holdings in UnitedHealth Group were worth $3,460,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Bayforest Capital Ltd increased its holdings in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. O Brien Wealth Partners LLC increased its stake in UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after purchasing an additional 37 shares in the last quarter. Nova Wealth Management Inc. lifted its stake in UnitedHealth Group by 339.1% during the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock valued at $53,000 after buying an additional 78 shares in the last quarter. Finally, Cloud Capital Management LLC purchased a new position in shares of UnitedHealth Group in the first quarter worth approximately $53,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.0%

Shares of NYSE:UNH opened at $356.53 on Monday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a fifty day moving average price of $329.38 and a 200 day moving average price of $342.24. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $322.90 billion, a PE ratio of 15.45, a P/E/G ratio of 2.31 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on UNH shares. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Royal Bank Of Canada reduced their price objective on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Wednesday, October 8th. Barclays raised their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Finally, JPMorgan Chase & Co. increased their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $385.13.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.